Logo image of EQS

EQUUS TOTAL RETURN INC (EQS) Stock Fundamental Analysis

NYSE:EQS - New York Stock Exchange, Inc. - US2947661003 - Common Stock - Currency: USD

1.448  0 (-0.14%)

Fundamental Rating

4

Overall EQS gets a fundamental rating of 4 out of 10. We evaluated EQS against 235 industry peers in the Capital Markets industry. EQS has a great financial health rating, but its profitability evaluates not so good. EQS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EQS has reported negative net income.
In the past year EQS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: EQS reported negative net income in multiple years.
In multiple years EQS reported negative operating cash flow during the last 5 years.
EQS Yearly Net Income VS EBIT VS OCF VS FCFEQS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -20.35%, EQS is doing worse than 89.36% of the companies in the same industry.
EQS has a Return On Equity of -39.85%. This is amonst the worse of the industry: EQS underperforms 86.38% of its industry peers.
Industry RankSector Rank
ROA -20.35%
ROE -39.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EQS Yearly ROA, ROE, ROICEQS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

With an excellent Gross Margin value of 89.76%, EQS belongs to the best of the industry, outperforming 93.19% of the companies in the same industry.
EQS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EQS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-1.74%
EQS Yearly Profit, Operating, Gross MarginsEQS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K

7

2. Health

2.1 Basic Checks

EQS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EQS Yearly Shares OutstandingEQS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
EQS Yearly Total Debt VS Total AssetsEQS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.16, we must say that EQS is in the distress zone and has some risk of bankruptcy.
EQS has a Altman-Z score of -0.16. This is in the lower half of the industry: EQS underperforms 77.87% of its industry peers.
EQS has a debt to FCF ratio of 1.18. This is a very positive value and a sign of high solvency as it would only need 1.18 years to pay back of all of its debts.
EQS has a better Debt to FCF ratio (1.18) than 87.66% of its industry peers.
A Debt/Equity ratio of 0.94 indicates that EQS is somewhat dependend on debt financing.
EQS has a Debt to Equity ratio (0.94) which is comparable to the rest of the industry.
Although EQS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 1.18
Altman-Z -0.16
ROIC/WACCN/A
WACCN/A
EQS Yearly LT Debt VS Equity VS FCFEQS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

A Current Ratio of 21.53 indicates that EQS has no problem at all paying its short term obligations.
EQS's Current ratio of 21.53 is amongst the best of the industry. EQS outperforms 99.15% of its industry peers.
A Quick Ratio of 21.53 indicates that EQS has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 21.53, EQS belongs to the best of the industry, outperforming 99.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 21.53
Quick Ratio 21.53
EQS Yearly Current Assets VS Current LiabilitesEQS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

3

3. Growth

3.1 Past

EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -240.63%.
Looking at the last year, EQS shows a very strong growth in Revenue. The Revenue has grown by 410.04%.
The Revenue has been growing by 29.40% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-240.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1075%
Revenue 1Y (TTM)410.04%
Revenue growth 3YN/A
Revenue growth 5Y29.4%
Sales Q2Q%74.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EQS Yearly Revenue VS EstimatesEQS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2023 2024 200K 400K 600K 800K 1M

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EQS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EQS Price Earnings VS Forward Price EarningsEQS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, EQS is valued cheaply inside the industry as 99.15% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.52
EV/EBITDA N/A
EQS Per share dataEQS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EQS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EQUUS TOTAL RETURN INC

NYSE:EQS (7/21/2025, 7:00:00 PM)

1.448

0 (-0.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-18 2025-08-18
Inst Owners1.09%
Inst Owner Change0%
Ins Owners36.85%
Ins Owner Change0%
Market Cap19.68M
Analysts0
Price TargetN/A
Short Float %0.36%
Short Ratio1.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.49
P/FCF 0.52
P/OCF 0.52
P/B 0.4
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)-1.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.8
FCFY193.11%
OCF(TTM)2.8
OCFY193.11%
SpS0.09
BVpS3.61
TBVpS3.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.35%
ROE -39.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.76%
FCFM 2992.13%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-1.74%
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 1.18
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 21.53
Quick Ratio 21.53
Altman-Z -0.16
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-240.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1075%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)410.04%
Revenue growth 3YN/A
Revenue growth 5Y29.4%
Sales Q2Q%74.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y174.51%
FCF growth 3Y21.64%
FCF growth 5YN/A
OCF growth 1Y174.51%
OCF growth 3Y21.64%
OCF growth 5YN/A